Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 28: | Line 28: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Cutaneous squamous cell carcinoma''' | ||
| style="background: #F5F5F5; padding: 5px;" |pain | |||
| style="background: #F5F5F5; padding: 5px;" |erythema | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |indurated | |||
| style="background: #F5F5F5; padding: 5px;" |hyperkeratotic | |||
| style="background: #F5F5F5; padding: 5px;" |increased size | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| Line 36: | Line 41: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |skin biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* 60 percent of squamous cell carcinomas occur at the site of a previous actinic keratosis | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | ||
| Line 143: | Line 144: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | * large, hyperchromatic, oval nuclei and little cytoplasm | ||
* well differentiated and cells appear histologically similar to basal cells of the epidermis | |||
| style="background: #F5F5F5; padding: 5px;" |skin biopsy | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| Line 554: | Line 557: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Benign hereditary intraepithelial dyskeratosis''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Revision as of 15:27, 30 January 2019
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | ||||||||||||||
| Lab Findings | Imaging | Histopathology | |||||||||||||
| Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
| Cutaneous squamous cell carcinoma | pain | erythema | indurated | hyperkeratotic | increased size | skin biopsy |
| ||||||||
| Actinic keratoses | |||||||||||||||
| Merkel cell carcinoma | |||||||||||||||
| Prurigo nodules | |||||||||||||||
| Paget disease | |||||||||||||||
| Amelanotic melanoma | |||||||||||||||
| Superficial basal cell carcinoma |
|
skin biopsy | |||||||||||||
| Inflamed seborrheic keratosis | |||||||||||||||
| Viral warts | |||||||||||||||
| Bowenoid papulosis | |||||||||||||||
| Nummular eczema | |||||||||||||||
| Psoriasis | |||||||||||||||
| Basal cell carcinoma | |||||||||||||||
| Atypical fibroxanthoma | |||||||||||||||
| Amelanotic melanoma | |||||||||||||||
| Cutaneous metastases of internal malignancy | |||||||||||||||
| Pyoderma gangrenosum | |||||||||||||||
| Venous stasis ulcers | |||||||||||||||
| Sebaceous Hyperplasia | |||||||||||||||
| Traumatic ulcers | |||||||||||||||
| Bowen Disease | |||||||||||||||
| Sebaceous Hyperplasia | |||||||||||||||
| Trichoepithelioma | |||||||||||||||
| Allergic Contact Dermatitis | |||||||||||||||
| Atopic Dermatitis | |||||||||||||||
| Atypical Fibroxanthoma | |||||||||||||||
| Benign Skin Lesions | |||||||||||||||
| Chemical Burns | |||||||||||||||
| Limbal Dermoid | |||||||||||||||
| Sebaceous cell carcinoma | |||||||||||||||
| rhabdomyosarcoma | |||||||||||||||
| Benign hereditary intraepithelial dyskeratosis | |||||||||||||||
| Nevus | |||||||||||||||
| primary acquired melanosis | |||||||||||||||
| HPV | |||||||||||||||
| fibrous xanthoma | |||||||||||||||
| Juvenile xanthogranuloma | |||||||||||||||